Figure 7.
CGIC (left panel) and (right panel) ratings, both at the end of the 12-week observation.
Notes: Summary percentages for the “very much improved” and “much improved” categories for both scales were significantly higher (CGIC: P=0.045; PGIC: P=0.035) for the OXN group (n=128) vs the TAP group (n=133).
Abbreviations: CGIC, Clinician global impression of change; PGIC, patient global impression of change; TAP, tapentadol; OXN, oxycodone/naloxone.